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Abstract
Objective—Little is known regarding eye care utilization among low income persons with 
diabetes, especially African Americans.
Methods—A retrospective cohort study with two-years of follow-up examined eye care 
utilization among adult diabetes patients seen in 2007 in the internal medicine clinic of a large, 
urban, county hospital that serves primarily low income, non-Hispanic African American patients. 
Patients with a history of retinopathy and macular edema or a current diagnosis indicating 
ophthalmic complications were excluded. Eye care utilization was defined dichotomously as 
whether or not patients had a visit to the eye clinic for any eye care examination or procedure. We 
estimated crude and adjusted rate ratios (aRRs) and 95% confidence intervals (CIs) for the 
association between eye care utilization and selected clinical and demographic characteristics.
Results—There were 867 patients with diabetes identified: 61.9% women, 76.2% non-Hispanic 
African American, 61.3% indigent, and average age 51.8 years. Eye care utilization was 33.2% 
within one-year and 45.0% within two-years. For patients 19–39 years of age compared to those 
65+ years, significantly decreased eye care utilization was observed within one-year (aRR=0.48, 
95% CI 0.27–0.84) and within two-years (aRR=0.61, 95% CI 0.38–0.99).
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Conclusions—Overall eye care utilization was low. Additional education efforts to increase the 
perception of need among urban minority populations may be enhanced if focused on younger 
people with diabetes.
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INTRODUCTION
Diabetic retinopathy is the leading cause of new cases of blindness among working age 
adults in the United States.1 The prevalence of diabetic retinopathy and vision threatening 
diabetic retinopathy is estimated to be 3.8% and 0.6%, respectively, among the US 
population 40 years and older.2 Those with diabetes are also at increased risk for 
glaucoma,3,4 and cataracts.5 Compared to non-Hispanic whites, non-Hispanic African 
Americans and Mexican Americans have a two-fold increased risk of being diagnosed with 
diabetes.6 Furthermore, non-Hispanic African Americans and Mexican Americans already 
diagnosed with diabetes have increased prevalences of diabetic retinopathy, i.e., 46% and 
84% higher, respectively, than non-Hispanic whites.7 In addition, these groups are 
diagnosed with diabetic retinopathy of greater severity than non-Hispanic whites,7 likely due 
to differences in socioeconomic status that results in poor glycemic control,8 and disparities 
in quality and access to health care.9,10
Visual symptoms may not occur until retinopathy is well advanced and not compliant to 
treatment. Therefore, the American Diabetes Association, the American Academy of 
Ophthalmology, and the American Optometric Association recommend that persons with 
type 1 diabetes have an annual dilated eye examination after 5 years of diagnosis and that 
persons with type 2 diabetes have a dilated eye examination at time of diagnosis and 
annually thereafter.11–13 Those with diabetes who received recommended eye care over a 
three year period had earlier diagnosis of diabetic retinopathy and lower rates of low vision 
and blindness.14 Nonetheless, the proportion of diabetes patients who receive an annual eye 
examination is low. For example, Saaddine et al.15 reported a dilated eye examination rate 
of 63.3% for the previous year among adults with self-reported diabetes. Among women 40 
years of age and older diagnosed with diabetic retinopathy, those without eye care insurance 
less frequently followed recommended guidelines for visiting an eye-care provider.16 
Overall, those with vision care insurance are more than twice as likely to have an annual eye 
examination. Other factors associated with increased likelihood of eye care utilization 
include higher income, and greater educational attainment.17
There are over 100 public hospitals and health systems in the U.S. and these health systems 
deliver 25% of the uncompensated care in the U.S., including 35 million ambulatory care 
visits each year.18 Patients with diabetes who rely on safety-net health systems for 
healthcare are at increased risk for diabetic eye diseases because many are 
socioeconomically disadvantaged and medically underserved.19 Low socioeconomic status 
is a risk factor for visual impairment,20 due to decreased preventive services and poor 
continuity of care, resulting in delayed diagnoses and increased morbidity.21 Previous 
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studies of low income diabetic populations from urban areas have focused primarily on 
Hispanic populations,19,22 and little is known about eye care utilization among low income 
non-Hispanic African American adults with diabetes. The objective of this study was to 
investigate eye care utilization among patients with diabetes who are seen in a county 
hospital clinic in the South that primarily serves high risk low income patients who are 
predominantly non-Hispanic African Americans.
METHODS
The current investigation is a retrospective cohort study of eye care utilization among 
patients with diabetes who visited an out-patient medical clinic operated by Jefferson Health 
System at Cooper Green Mercy Hospital, a large “public safety net” hospital in Birmingham 
Alabama and operated by Jefferson County Alabama.23 Jefferson County covers 
approximately 1,100 square miles. In 2010, the county had a population of 658,466, of 
whom 51% were non-Hispanic white and 42% non-Hispanic African American; overall, 
15.5% of the county’s residents live below the poverty level.24 Cooper Green Mercy 
Hospital offers health care services to all residents of Jefferson County, and includes out-
patient clinics for internal medicine and ophthalmology; out-of-pocket fees are based on 
family size and income. The Institutional Review Boards of the University of Alabama at 
Birmingham and Cooper Green Mercy Hospital reviewed and approved the study protocol 
before it was initiated.
Study population
The study population comprised patients 19 years of age and older diagnosed with diabetes 
who visited the facility’s internal medicine outpatient clinic in 2007. Patients with diabetes 
were identified through the hospital’s electronic administrative records. For January 1987 
through July 2011, all patient records containing an International Classification of Disease, 
Ninth Revision (ICD-9) diagnosis code of 250.0–250.9 were classified as having diabetes. 
Previous research has reported that a single out-patient visit for ICD-9 code 250 has high 
sensitivity and specificity for the identification of diabetes patients.25 For those patients with 
diabetes who visited the internal medicine clinic in 2007, the date of their first clinic visit in 
2007 was defined as an index date. Excluded from the study were patients with an ICD-9 
indicating ophthalmic complications (250.5) at the time of their index date, and patients who 
had an ICD-9 in their pre-2007 history indicating retinopathy or macular edema (362.0–
362.9). For the remaining patients, two-year follow-up began the day after their index date 
with the primary outcomes of interest being eye care utilization within one- and two-years. 
Follow-up was carried out by linking patients’ personal identifiers, i.e., medical record 
numbers, to electronic records of the hospital’s billing and accounting system which 
included dates and procedures of patient encounters in the hospital’s ophthalmology clinic.
Variables of interest
Patient visits to the eye clinic for any eye care procedures were considered as positive 
outcomes for eye care utilization, which included: new or established patient visits; 
examinations (e.g., ophthalmoscopy, refractions); diagnostic testing (e.g., A-scan ultrasound 
biometry); and treatment (e.g., intravitreal injection of medication). The outcome was 
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defined did/did not have at least one eye care visit within one- and two-years of follow-up. 
Independent variables included patient demographics (sex, race/ethnicity, age, and marital 
status), severity of diabetes, time since diabetes diagnosis, and insurance status. Race/
ethnicity was categorized into mutually exclusive groups as non-Hispanic African 
American, non-Hispanic white, Hispanic, and other. Age was categorized as 19–39, 40–64, 
and 65 years and older. Marital status was categorized as married and not married (i.e., 
divorced, separated, single, and widowed). Diabetes severity was classified into three 
mutually exclusive groups: controlled without complications (ICD-9=250.00, 250.01); 
uncontrolled without complications (ICD-9=250.02, 250.03); and with complications 
(ICD-9=250.40, 250.50, 250.60, 250.90). Previous research has used similar classification 
schemes based on ICD-9 codes to differentiate glycemic control but without the additional 
categorization for complications.26,27 Time since diabetes diagnosis was derived from the 
date when a diabetes diagnosis code first appeared in the hospital’s administrative records 
and was categorized as less than one year, one to four years, five to nine years, and ten or 
more years. Finally, patients’ insurance status was categorized as indigent, Medicare, 
Medicaid, self-pay, and private insurance (e.g., Blue Cross). Those classified as indigent 
were below the federal poverty guidelines scale based on income and number of household 
members,(28) but were not covered by Medicaid.
Statistical analysis
Crude and adjusted rate ratios (RRs) and their corresponding 95% confidence intervals (CIs) 
were calculated for eye care utilization within one-year and within two-years. Associations 
were examined for demographic variables (sex, race/ethnic group, age group, marital status), 
diabetes severity group, time since diabetes diagnosis, and insurance status. All covariates 
were included in multivariable models used to estimate adjusted RRs; however, because of 
high collinearity, age was not included in the regression model used to estimate the 
association with time since diabetes diagnosis, and time since diabetes diagnosis was not 
included in the regression model used to estimate the association with age. All statistical 
analyses were done using SAS 9.2.
RESULTS
Overall, 1,157 patients with diabetes were identified as visiting the internal medicine out-
patient clinic in 2007 but 290 were excluded for having a previous retinopathy diagnosis or 
current diabetes diagnosis with ophthalmic complications, resulting in 867 patients with 
diabetes included in the study. One- and two-year eye care utilization rates were 33.2% and 
45.0%, respectively. Only one patient was missing values for any of the variables of interest, 
i.e., one subject was missing insurance information and did not contribute information for 
crude analysis of this variable and in the adjusted analysis. The majority of patients with 
diabetes were women (61.9%), and non-Hispanic African American (76.2%). Average age 
was 51.8 years and ranged from 20 to 90 years, and 74.1% were between 40 and 64 years of 
age (Table 1). Most patients were not married (80.4%). Average time since diabetes 
diagnosis was 3.3 years (SD=3.7). Approximately 27% of the cohort had been newly 
diagnosed, i.e., within one year previous to their index date, and 54.7% diagnosed one to 
four years. Most patients were uninsured (i.e., 61.4% indigent and 3.1% self-pay) followed 
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by Medicare (21.8%), Medicaid (11.8%) and private insurance (1.8%). Based on the ICD-9 
diagnosis codes (Table 2), 37.1% (N=322) of patients had controlled diabetes, but a larger 
number (61.9%, N=537) had uncontrolled diabetes. Only eight patients had diabetes with a 
non-ocular complication, the majority neurological (N=7).
There were no significant differences in eye care utilization by gender (Table 3). Compared 
to non-Hispanic white patients, more non-Hispanic African Americans and Hispanics 
utilized hospital eye care services within one- and two-years but associations did not reach 
statistical significance. Relative to the 65+ age group, the 19–39 age group was less likely to 
utilize eye care services both within one- (aRR=0.48, 95% CI 0.27–0.84) and two-years 
(aRR=0.61, 95% CI 0.38–0.99). There were no significant differences by time since diabetes 
diagnosis. Patients with uncontrolled diabetes were similar in eye care utilization patterns to 
those with controlled diabetes. Finally, compared to patients classified as indigent, Medicaid 
patients received less eye care services within one- (aRR=0.76, 95% CI 0.51–1.15) and two-
years (aRR=0.73, 95% CI 0.51–1.04) but the associations failed to reach statistical 
significance; similar decreased but non-significant eye care utilization patterns were 
observed for the other insurance type groups.
DISCUSSION
This study provides an evaluation of eye care utilization among diabetes patients at a county 
public hospital that largely serves a mostly non-Hispanic African American population, 
most of whom are uninsured. Within one- and two-years of follow-up, 33.2% and 45.0% of 
patients, respectively, received any of the study’s defined eye care services from the 
hospital’s ophthalmology out-patient clinic. Investigations of eye care utilization among 
people with diabetes by race and ethnicity have focused primarily on Hispanic populations, 
but not on non-Hispanic African Americans. Mier et al. investigated older Mexican 
Americans with diabetes along the Texas border and reported that 61.7% of subjects 
received an eye examination in the previous year and that those with health insurance were 
over five times as likely to have an eye examination;29 whereas Pérez et al. investigated 
adults with diabetes residing in Puerto Rico and reported that 49.2% received an annual 
dilated eye examination.30 Both studies reported higher one-year eye examination rates than 
the current study. Paz et al.,22 however, investigated eye care utilization rates among an 
urban Hispanic cohort of people with diabetes and reported rates (35%) that were similar to 
the current study.
Previous research of eye care utilization among non-Hispanic African Americans with 
diabetes is scarce. In the current study, 33.7% and 46.1% of non-Hispanic African American 
patients, respectively, received eye care services within one- and two-years of follow-up. An 
earlier study of newly presenting diabetes patients to the eye clinic of an inner city public 
hospital reported similar demographic and clinical characteristics as the current study.19 
Investigators reported that 32% of patients were deemed to have had appropriate timing of 
ophthalmic surveillance.19 A recent assessment of a community based educational 
intervention to increase eye care utilization among non-Hispanic African American adults 
with diabetes reported pre- and post-intervention dilated eye examination rates that were 
much higher than the current study.31 Overall, approximately 70% of subjects reported 
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receiving a dilated eye exam within the previous year during both the pre- and post-
intervention periods; in addition, those living in the community that received eye care 
education were significantly more likely (OR=1.59) to have received a dilated eye 
examination in the preceding 12-months.31. However, unlike the current study, outcome and 
covariate information was from self-report; in addition, over 80% of subjects reported 
having health insurance, indicating that subjects were dissimilar to those in our cohort. 
Previous research has reported that eye care utilization estimates based on self-report will 
overestimate the number receiving an eye exam within the previous year.32
A large proportion of the current study’s diabetes patients had uncontrolled diabetes without 
complications. Research suggests that only a small proportion (36%) of diabetes patients 
nationwide have their glycemia under control.33 Uncontrolled diabetes is a risk factor for 
diabetic retinopathy;34 in the current study, focused on a safety net hospital primarily 
serving the uninsured, the uncontrolled diabetes group’s utilization of eye care services was 
similar to that of diabetes patients with controlled diabetes.
Eye care utilization was not significantly different by insurance group. Nonetheless, even 
when cost of care is subsidized or removed as a barrier, as it is for patients of this facility, 
eye care utilization may remain low. Primary barriers related to individuals’ decisions not to 
seek eye care for diabetic retinopathy have been ranked from most important to least as 
being related to behavior and culture, costs, and geographic accessibility.35 Barriers to eye 
care, however, are not equivalent for all groups and an investigation of perceptions and 
beliefs of vision care among older African Americans who resided in Birmingham and 
Montgomery, the two largest cities in Alabama, reported that the most frequently cited 
barrier to care was transportation, followed by trusting the doctor, communicating with the 
doctor, and costs.36 Rask et al. (1994) investigated a patient population that was similar to 
the current study’s and reported that lack of transportation was significantly associated with 
both not having a source for regular care and in delay of care for new health problems.37 
Low educational attainment has been reported to be significantly associated with patients 
choosing to delay care,37 and racial differences in health literacy might contribute to African 
Americans being less familiar with eye disease.38,39 In addition, researchers have reported 
that 87% of African American study participants have the mistaken belief that eye problems 
are always accompanied by symptoms, and that only a small proportion of participants had 
ever heard of retinopathy with less that 10% able to correctly describe the eye disease.40 
Older African Americans have identified difficulty in communicating with eye care 
providers as a barrier to seeking eye care.36,41 Other research supports the importance of 
physician-patient communications in race based health disparities.42
The study was strengthened by reliance on objective information sources, i.e., electronic 
administrative records for the identification of diabetes patients and billing and accounting 
records for their eye care utilization over the two year follow-up period. In addition, the 
health system predominantly serves non-Hispanic African Americans who are largely 
uninsured, the target population of interest. We excluded patients who had a previous 
diagnosis of retinopathy or macular edema, which increased internal validity by insuring that 
the study subjects were free of ophthalmic complications of diabetes before follow-up; 
alternatively, restriction limits the study’s external validity and generalizability. Limitations 
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of the study should be acknowledged when interpreting the results. Because the study was 
based on administrative data, it was limited in the number of patient and clinical 
characteristics that could be examined. Furthermore, a large proportion (21.8%) of patients 
were covered by Medicare, thus they had healthcare options unavailable to patients covered 
by Medicaid and no health insurance. It is noteworthy that 61.9% (N=117) of Medicare 
patients were less than 65 years of age at the time of their index date, indicating that a large 
proportion was disabled. It is possible that Medicare patients might have gone to other 
facilities to receive eye care.
Loss to follow-up (death, censoring, etc.) may potentially influence results; we are unable to 
determine which patients died during follow-up. However, an analysis of health care 
services utilization at the facility through July 2011 indicates that, among the 477 patients 
who did not visit the ophthalmology clinic during the two-year follow-up period, 87.4% 
(N=417) had used other hospital services within two-years of their follow-up index date. 
Furthermore, 20.3% (N=97) of patients who did not receive study defined eye care services 
during follow-up, did so after the two-year follow-up period.
In summary, the current study indicates that patients with diabetes managed in the internal 
medicine clinic of a large public safety net hospital have lower eye care utilization rates than 
national estimates but rates are similar to those reported by others for minority populations 
with diabetes in urban areas.19,22 Young diabetes patients had significantly lower eye care 
utilization implying that educational efforts aimed at increasing the perception of need for 
eye care among similar populations should focus on younger patients.
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Table 1
Patient demographics, time since diagnosis, and insurance type at time of 2007
Characteristics N=867
Sex (%)
 Male 330 (38.1)
 Female 537 (61.9)
Race/Ethnicity (%)
 Non-Hispanic African American 661 (76.2)
 Non-Hispanic White 164 (18.9)
 Hispanic 26 (3.0)
 Other 16 (1.9)
Age, mean (SD) 51.8 (11.9)
Age group (%)
 19–39 140 (16.2)
 40–64 642 (74.1)
 65+ 85 (9.8)
Marital status (%)
 Married 170 (19.6)
 Not married 697 (80.4)
Time since diabetes diagnosis, mean (SD) 3.3 (3.7)
Time since diabetes diagnosis group (%)
 < 1 year (newly diagnosed) 237 (27.3)
 1 to 4 years 474 (54.7)
 5 to 9 years 101 (11.7)
 10+ years 55 (6.3)
Insurance type (%)
 Indigent 532 (61.4)
 Medicare 189 (21.8)
 Medicaid 102 (11.8)
 Self-pay 27 (3.1)
 Private 16 (1.8)
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Table 2
Diabetes severity group and primary ICD-9 diabetes diagnosis
N=867
Controlled 322 (37.1%)
 Type 2 diabetes mellitus (250.00) 300
 Type 1 diabetes mellitus (250.01) 22
Uncontrolled 537 (61.9%)
 Type 2 diabetes mellitus (250.02) 489
 Type 1 diabetes mellitus (250.03) 48
With complications 8 (0.9%)
 Renal manifestations (250.40) 1
 Neurological manifestations (250.60) 7
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